FETAL FIBRONECTIN (FFN)
: Core Lab
: Specimen should be cervicovaginal secretions obtained under sterile speculum conditions using the ADEZA Specimen Collection Kit. No other sample collection method is acceptable for this assay.
: Cervicovaginal secretions
: Room temperature
Reasons for Rejection
: Frozen specimen. Not in Adeza Collection Kit.
: STAT testing is available
: Presence of fetal fibronectin (ffN) in symptomatic women indicates an increased risk for preterm delivery; absence of ffN in symptomatic women indicates decreased intervention. Utilization of ffN testing in symptomatic women may greatly reduce costs associated with treatment of suspected preterm labor. This test has been recommended by the American College of Obstetricians and Gynecologists (ACOG), who currently supports ffN testing as an adjunctive diagnostic tool in symptomatic patients. ffN testing has a positive predictive value of 40-60% and a negative predictive value of 99.5%.
: Collection kits are available from the laboratory. Douches, white blood cells, red blood cells, bacteria, and bilirubin may cause test interference.
Search Options for the Test Directory:
1. Enter the test name in the Keyword search field.
Hint: You can also enter any part of the test name to expand the search.
(Example: you can type "west" or "sed" or "rate" to find Westergren Sedimentation Rate)
2. Enter the Vanderbilt Test Code, if known.
3. Choose one of the letter boxes to display a list of all test names and keywords starting with that letter.
If you are unable to find a test in our directory, please contact VPLS at
1-800-551-5227 or e-mail firstname.lastname@example.org.